Truist Raises Its Price Target on BridgeBio Pharma, Inc. (BBIO) to $95 and Maintains a Buy Rating

BridgeBio Pharma, Inc. (NASDAQ:BBIO) is among the 10 Fastest Growing NASDAQ Stocks to Buy.

On February 25, 2026, Truist expert Danielle Brill raised the firm’s terms people connected BridgeBio Pharma, Inc. (NASDAQ:BBIO) to $95 from $86 and maintained a Buy standing connected the shares. The expert noted that the institution had pre-announced Q4 Attruby income of $146M successful January, representing a 35% summation from Q3 and exceeding quarterly estimates. The show was driven by an acceleration successful the gait of caller diligent additions, which the expert said appears to beryllium continuing.

Also connected February 25, 2026, Morgan Stanley expert Sean Laaman raised the firm’s terms people connected BridgeBio Pharma, Inc. (NASDAQ:BBIO) to $98 from $96 and reiterated an Overweight standing aft updating estimates pursuing the company’s Q4 report.

On February 24, 2026, BridgeBio Pharma, Inc. (NASDAQ:BBIO) reported Q4 EPS of ($1.00), compared with statement estimates of (67c). The institution reported Q4 gross of $154.18M, supra the $149.07M statement estimate. Co-Founder and CEO Neil Kumar said the institution is reflecting connected its advancement implicit the past decade, highlighting 3 palmy Phase 3 readouts delivered wrong a small implicit 3 months. Kumar said the results show the rigor of the company’s subject and expressed anticipation that the advancement could pb to six approved products arsenic the institution closes its archetypal decade.

BridgeBio Pharma, Inc. (NASDAQ:BBIO) discovers, develops, and delivers medicines for patients with familial diseases.

While we admit the imaginable of BBIO arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 12 Best Tech Stocks that Beat Earnings Estimates and 40 Most Popular Stocks Among Hedge Funds Heading Into 2026

Disclosure: None. Follow Insider Monkey connected Google News.